Biopharma just can’t get enough of Epic Sciences | from Flow Cytometry to Cytomics | Scoop.it
From medcitynews.com - April 28, 2017 8:15 AM
Epic Sciences is one of the coolest kids on the biopharma block, with a new $40 million Series D financing round and a whopping 42 industry partnerships built around its novel liquid biopsy platform. For a team of just 70, the San Diego startup is doing pretty well.